 |
|
|
|
 |
|
Table 2
|
|
Coordinated expression of PML and HLA in prostate cancer.
|
Expression
Pattern
|
Frequency
(Observed/Total)
|
|
Down
regulation of HLA among all samples
|
81% (30/37)
|
|
Concordant down regulation of HLA and PML
|
87% (26/30)
|
|
Concordant expression of PML and HLA
|
100% (7/7)
|
|
Defective HLA expression in the absence of PML down-regulation
|
13% (4/30)
|
|
Defective
PML expression with normal HLA expression
|
0% (0/7)
|
|
|
|
|
|
|
Copyright
© 2003 by Pan Zheng